Clinical Trial: A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07153796) titled 'A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia' on Sept. 03.

Brief Summary: This is a single arm open-label phase 2 trial to study the safety and efficacy of SC Blinatumomab in combination with low-intensity chemotherapy for older or unfit patients with B-ALL.

Study Start Date: Feb. 28, 2026

Study Type: INTERVENTIONAL

Condition: B-cell Acute Lymphoblastic Leukemia

Intervention: DRUG: Blinatumomab

Given by IV

DRUG: Mini-CVD

Given by IV

DRUG: MTX/ARA-C

Given by IV

Recruit...